Growth without burning cash—that's what made brokerages confident
In the first days of June 2026, a chorus of major global brokerages turned their gaze toward India, initiating and affirming buy ratings across e-commerce, insurance, education, pharma, metals, and aviation — sectors as varied as the country's own economic ambitions. The signal was less about any single company than about a broader conviction: that Indian enterprises have entered a phase where scale and profitability are no longer in tension. From Meesho's cash-generating logistics network to IndiGo's 901-aircraft order book, the argument being made is structural, not merely cyclical — a wager on India's place in a reordering world.
- A single trading day saw Jefferies, HSBC, DAM Capital, JPMorgan, Macquarie, Nuvama, Kotak, and CLSA all move on Indian equities simultaneously, creating an unusual density of institutional conviction.
- The urgency behind the ratings is geopolitical as much as financial — China+1 diversification is redirecting hundreds of millions in pharma contracts toward Indian CDMOs, and Guinea's bauxite restrictions are lifting aluminum prices in ways that directly benefit NALCO.
- Execution risk looms large: Meesho must sustain 25% annual merchandise growth through 2030, PhysicsWallah must triple EBITDA while expanding offline centers, and IndiGo must absorb a near-doubling of passenger traffic without losing operational discipline.
- The current trajectory is one of cautious institutional optimism — brokerages are betting on structural tailwinds, but they are watching margin timelines, international expansion, and competitive intensity in quick commerce as the tests that will validate or unwind the thesis.
On a single trading day in early June, major investment banks moved in concert across Indian equities, initiating fresh buy ratings on companies spanning social commerce, insurance, education technology, metals, pharma manufacturing, and aviation. The breadth of the move suggested not opportunism but conviction — a shared read that Indian companies had crossed into a phase of sustainable, profitable growth.
Jefferies opened on Meesho with a buy and a Rs 225 target, drawn to the platform's loyal user base, deep merchant network, and a logistics operation efficient enough to generate cash as it scales rather than consume it. The firm forecast 25% annual growth in net merchandise value through fiscal 2030 and a path to positive EBITDA margins — notable for a social commerce player in a sector where profitability has often been elusive.
HSBC initiated on Max Financial Services at Rs 2,120, pointing to Axis Max Life as one of India's fastest-growing life insurers, with margins holding steady even through expansion — a sign of operational discipline. DAM Capital's buy on PhysicsWallah at Rs 140 rested on a rarer achievement still: an ed-tech company that had scaled without hemorrhaging cash, with EBITDA expected to grow at 71% annually as its offline learning centers matured and its centralized content infrastructure generated operating leverage.
Beyond the initiations, the upgrades told their own story. JPMorgan lifted its target on Aegis Logistics as LPG supply pressures eased. HSBC held its buy on NALCO as Guinea's bauxite export restrictions pushed global alumina prices higher. Macquarie named Divi's Laboratories, Cohance, and Syngene as outperformers in the CDMO space, arguing that restrictions on China's WuXi AppTec could redirect roughly $700 million in annual business toward Indian competitors — a structural windfall, not a temporary one.
In aviation, Nuvama raised its IndiGo target to Rs 5,335, anchored by a forecast that Indian passenger traffic would double by fiscal 2035 and an order book of 901 aircraft providing long-term visibility. CLSA held its outperform on State Bank of India, noting the bank's salary account franchise had crossed 20 million accounts. Macquarie maintained its view on Lenskart, expecting earnings per share to triple through fiscal 2029.
Taken together, the day's activity amounted to a thesis about India's structural position — in supply chains being redrawn away from China, in consumer markets still early in their digital adoption, and in industrial sectors where global supply constraints are doing some of the work for domestic champions. Whether the companies can execute on the timelines brokerages have sketched will be the test that separates conviction from optimism.
On a single trading day in early June, a cluster of major investment banks and brokerages moved in concert, initiating fresh buy ratings across a diverse set of Indian companies. The signal was unmistakable: optimism about growth, efficiency, and structural tailwinds across multiple sectors.
Jefferies opened a new position on Meesho, the social commerce platform, with a buy rating and a price target of Rs 225. The thesis rested on what the firm saw as a durable competitive advantage: a loyal user base, a deep network of small merchants and suppliers, and a logistics operation efficient enough to keep costs down. Jefferies forecast that Meesho's net merchandise value—the total transaction volume on the platform—would grow at 25 percent annually through fiscal 2030, while the company would reach an adjusted EBITDA margin of around 3 percent by that same year. Critically, the firm noted that Meesho carried a net cash balance sheet and operated with negative working capital, meaning the business generated cash as it scaled rather than consuming it.
HSBC initiated coverage of Max Financial Services, the insurance company, with a buy rating and a target of Rs 2,120. The bank highlighted Axis Max Life, the group's life insurance subsidiary, as one of India's fastest-growing life insurers. HSBC saw room for growth through distribution expansion and product diversification, and it emphasized that margins had remained stable even as the company expanded—a sign of operational discipline. The merger progress within the group was flagged as a potential catalyst.
DAM Capital, meanwhile, initiated a buy on PhysicsWallah, the education technology company, with a target of Rs 140. What distinguished PhysicsWallah in the crowded ed-tech space, according to DAM, was that it had achieved significant scale without sacrificing profitability—a rare feat in a sector littered with money-losing ventures. The firm expected revenue to grow at 24 percent annually and EBITDA to expand at 71 percent annually over the next two fiscal years, driven by expansion into new online categories and the maturation of its offline learning centers. The company's centralized content and faculty infrastructure was expected to generate operating leverage as it grew.
Beyond these three initiations, brokerages maintained or upgraded positions across other sectors. JPMorgan raised its price target on Aegis Logistics to Rs 1,150 from Rs 1,010, citing an easing LPG supply shortage and expecting EBITDA per tonne to remain sustainable at Rs 7,000 through fiscal 2028. HSBC maintained its buy on NALCO, the aluminum company, noting that Guinea's restrictions on bauxite exports were pushing up global prices for alumina and bauxite, while domestic aluminum premiums had reset higher—NALCO stood to benefit from these supply-side shifts.
In the pharmaceutical contract manufacturing space, brokerages saw a structural opportunity. Restrictions on WuXi AppTec, a major Chinese contract research and development manufacturer, were expected to redirect roughly $700 million in annual business toward Indian competitors. Jefferies named JSW Steel and Tata Steel as top picks in metals, arguing that historical patterns suggested stronger returns ahead despite elevated valuations. Macquarie rated Divi's Laboratories, Cohance, and Syngene as outperformers in the CDMO space, predicting that the Indian market could double in size over the medium term.
In aviation, Nuvama raised its price target on IndiGo to Rs 5,335 from Rs 5,054, citing expectations that Indian aviation passenger traffic would double by fiscal 2035. The airline's order book of 901 aircraft provided long-term visibility. In quick commerce, Kotak noted that the top three players had ended the fiscal year with 4,525 stores and quarterly net merchandise value of Rs 277 billion, though competitive intensity remained elevated. Macquarie maintained an outperform rating on Lenskart, the eyewear retailer, expecting EBITDA to grow at over 35 percent annually through fiscal 2029 and earnings per share to triple over the same period. CLSA maintained an outperform on State Bank of India, highlighting the bank's salary account franchise, which had crossed 20 million accounts, and ongoing operational improvements.
The breadth of the coverage initiation and upgrades reflected a market conviction that Indian companies across consumer, financial services, technology, and industrial sectors had moved into a phase of sustainable, profitable growth. The brokerages were betting not just on near-term earnings, but on structural advantages—supply-side constraints benefiting metals, China+1 diversification benefiting pharma, aviation capacity constraints benefiting airlines, and digital adoption benefiting e-commerce and fintech. Whether these companies could execute on the growth forecasts and margin timelines that brokerages had laid out would determine whether the optimism proved justified.
Citações Notáveis
One of the few Indian ed-tech companies to achieve scale without sacrificing profitability— DAM Capital on PhysicsWallah
Net cash balance sheet and negative working capital support capital-efficient growth— Jefferies on Meesho
A Conversa do Hearth Outra perspectiva sobre a história
Why did so many brokerages move at once on these stocks? Was there a trigger?
Not a single trigger, really. It felt more like a recognition that several sectors had matured enough to warrant fresh analysis. Meesho, PhysicsWallah, Max Financial—these weren't new companies, but they'd reached a scale where the unit economics became visible and defensible.
What's the common thread? What do Meesho and PhysicsWallah have in common that made brokerages confident?
Both had achieved something rare in their sectors: growth without burning cash. Meesho has negative working capital. PhysicsWallah is profitable at scale. In e-commerce and ed-tech, that's almost shocking. It meant the business model itself was sound, not dependent on endless capital infusions.
The pharma CDMO angle—is that really a $700 million opportunity, or are brokerages overselling it?
It's real, but it's not all going to Indian companies. China+1 means some work stays in China, some goes to Vietnam, some to India. But yes, Indian companies like Divi's and Sai Life Sciences have the small-molecule and peptide capabilities that matter. The question is execution and whether they can scale without losing margins.
Why is aviation suddenly so bullish? Isn't that a cyclical sector?
It is, but the cycle is long. Passenger traffic doubling by 2035 isn't a prediction—it's almost inevitable given India's GDP growth and rising middle class. IndiGo's order book of 901 aircraft means the company is betting on that too. The risk isn't the cycle; it's whether fuel costs or geopolitics disrupt the forecast.
What about the quick commerce call? Kotak said competitive intensity is elevated but still maintained a buy.
That's the tension. The market is brutal—four or five players fighting for share, margins compressed. But the brokerages think the top three will survive and consolidate. Blinkit's expected revival and improved discipline from market leaders suggest the bloodletting might be ending.
If all these stocks hit their price targets, what does that say about the market?
It says Indian equities are repricing around a new growth narrative. Not just GDP growth, but profitable growth—companies that can expand without destroying shareholder value. That's a shift from the last decade, where growth often meant losses.